Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...

MRK and Daiichi Sankyo's patritumab deruxtecan shows statistically significant progression-free survival improvement in ...

Immune checkpoint inhibitors are the superheroes of cancer therapy. | Immune checkpoint inhibitors are the superheroes of ...

Along with breast cancer, cervical cancer is among the most feared cancer diagnoses for women around the world.

The phase IIIA trials randomized 792 patients ages 12 and older with severe asthma in a 2:1 ratio to depemokimab (100 mg ...

Pharmaceutical companies are making investments in research of therapies that target three different antigen-binding sites.

What's the BIOSECURE Act? Why is Merck nonchalant about Summit's Keytruda rival? What did Roivant buy from Bayer? We answer ...

The US Department of Agriculture (USDA) has taken a significant step towards the approval of an H5N1 avian flu vaccine for ...

The final product processing segment is further categorized as small-molecule processing and biologics processing ...

Dr. Steve Caffé is an accomplished industry executive with over 25 years of expertise in global product development and ...

Chinese companies Innovent Biologics and GenFleet have recently secured approval from China’s National Medical Products ...